ATE320184T1 - Xylitolzusammensetzungen zur behandlung der oberen atmungsorgane - Google Patents

Xylitolzusammensetzungen zur behandlung der oberen atmungsorgane

Info

Publication number
ATE320184T1
ATE320184T1 AT99914103T AT99914103T ATE320184T1 AT E320184 T1 ATE320184 T1 AT E320184T1 AT 99914103 T AT99914103 T AT 99914103T AT 99914103 T AT99914103 T AT 99914103T AT E320184 T1 ATE320184 T1 AT E320184T1
Authority
AT
Austria
Prior art keywords
upper respiratory
treatment
respiratory organs
xylitol
xylitol compositions
Prior art date
Application number
AT99914103T
Other languages
German (de)
English (en)
Inventor
Alonzo H Jones
Original Assignee
Alonzo H Jones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26761708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE320184(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alonzo H Jones filed Critical Alonzo H Jones
Application granted granted Critical
Publication of ATE320184T1 publication Critical patent/ATE320184T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT99914103T 1998-03-24 1999-03-24 Xylitolzusammensetzungen zur behandlung der oberen atmungsorgane ATE320184T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7918498P 1998-03-24 1998-03-24
US09/220,283 US6054143A (en) 1998-03-24 1998-12-23 Xylitol delivery

Publications (1)

Publication Number Publication Date
ATE320184T1 true ATE320184T1 (de) 2006-04-15

Family

ID=26761708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99914103T ATE320184T1 (de) 1998-03-24 1999-03-24 Xylitolzusammensetzungen zur behandlung der oberen atmungsorgane

Country Status (16)

Country Link
US (2) US6054143A (pt)
EP (1) EP1063885B1 (pt)
JP (1) JP2002507548A (pt)
CN (1) CN1302183A (pt)
AT (1) ATE320184T1 (pt)
AU (1) AU748327B2 (pt)
CA (1) CA2321819C (pt)
DE (1) DE69930375T2 (pt)
DK (1) DK1063885T3 (pt)
ES (1) ES2161666T3 (pt)
IL (1) IL138467A0 (pt)
NO (1) NO331654B1 (pt)
NZ (1) NZ506557A (pt)
PT (1) PT1063885E (pt)
TR (1) TR200002739T2 (pt)
WO (1) WO1999048361A1 (pt)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery
CA2356637C (en) * 1998-12-22 2011-09-13 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
JP2001354549A (ja) * 2000-06-08 2001-12-25 Koike Kagaku Kk 鼻腔洗浄エアゾール製品
US6596284B1 (en) * 2002-04-30 2003-07-22 Thomas E. Fleming Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
US20040039042A1 (en) * 2002-08-23 2004-02-26 Fleming Thomas E. Method of transdermal drug delivery
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
ES2393786T3 (es) 2004-04-29 2012-12-28 Ribocor, Inc. Método para mejorar la eficacia ventilatoria
US20060034947A1 (en) * 2004-06-02 2006-02-16 Burr James B Erythritol compositions for nasopharynx cleansing
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
KR20070113281A (ko) * 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
WO2006099359A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
WO2006099325A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
US20060275223A1 (en) * 2005-06-02 2006-12-07 Burr James B Erythritol compositions for teeth and gums
US20070060639A1 (en) * 2005-09-09 2007-03-15 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids
DE602005013788D1 (de) * 2005-10-11 2009-05-20 ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung
US8337906B2 (en) * 2006-07-25 2012-12-25 Zinreich James Nasal composition
US20080026078A1 (en) * 2006-07-25 2008-01-31 Zinreich James Nasal composition
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
CN102462728A (zh) * 2010-11-17 2012-05-23 郭进军 一种治疗和预防细菌性上呼吸道感染的药物组合物
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
ITRM20110390A1 (it) 2011-07-21 2013-01-22 Eramo Alessandra D Prodotto per stimolare la produzione endogena di mediatori dell'infiammazione.
JP2015518006A (ja) 2012-05-25 2015-06-25 エクスクリア インコーポレイテッド キシリトール系の抗粘膜組成物及び関連する方法並びに組成物
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
CN103893158A (zh) * 2014-04-24 2014-07-02 山东福田药业有限公司 木糖醇在雾霾性呼吸系统疾病中的应用
CN105326786A (zh) * 2015-11-09 2016-02-17 合肥九研医药科技开发有限公司 一种鼻腔冲洗液组合物及其制备方法
EP3389629B1 (fr) 2015-12-17 2021-04-21 Urgo Recherche Innovation et Développement Composition liquide pour son utilisation comme solution nasale
US10959450B2 (en) * 2017-10-15 2021-03-30 Yu Heong Jun Food composition for relieving symptoms of allergic and autoimmune diseases
FR3088193B1 (fr) 2018-11-13 2021-01-22 Andrea Fox Composition aqueuse, son procede de fabrication, et dispositif d’administration nasal
US10874650B1 (en) * 2020-04-24 2020-12-29 Ferrer Medical Innovations, LLC Antiviral and virucidal nasal spray compositions and related treatment methods
US20230277424A1 (en) * 2022-03-03 2023-09-07 Profounda Health And Beauty Inc. Treatment composition for nasal and oral dryness, nosebleeds, and allergy symptoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1200940A (en) * 1966-11-19 1970-08-05 Takeda Chemical Industries Ltd A method for solubilising enduracidin and aqueous solutions thereof
DE2360414A1 (de) * 1972-12-05 1974-06-06 Ono Pharmaceutical Co Prostaglandin-zusammensetzungen
US4820506A (en) * 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
NL9000237A (nl) * 1990-01-31 1991-08-16 Re Novative Drugs For Dermatol Topicale farmaceutische composities voor de mondholte en vagina.
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
CZ88999A3 (cs) * 1996-09-12 1999-08-11 Smithkline Beecham Consumer Healthcare Gmbh Remineralizační prostředek
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery

Also Published As

Publication number Publication date
DE69930375D1 (de) 2006-05-11
PT1063885E (pt) 2006-05-31
AU3202099A (en) 1999-10-18
NZ506557A (en) 2003-01-31
EP1063885B1 (en) 2006-03-15
NO20004736D0 (no) 2000-09-22
CN1302183A (zh) 2001-07-04
ES2161666T1 (es) 2001-12-16
CA2321819A1 (en) 1999-09-30
JP2002507548A (ja) 2002-03-12
EP1063885A4 (en) 2002-09-18
WO1999048361A1 (en) 1999-09-30
NO331654B1 (no) 2012-02-13
US6258372B1 (en) 2001-07-10
DE69930375T2 (de) 2006-10-19
DK1063885T3 (da) 2006-07-24
AU748327B2 (en) 2002-05-30
CA2321819C (en) 2010-02-02
NO20004736L (no) 2000-10-11
TR200002739T2 (tr) 2000-11-21
IL138467A0 (en) 2001-10-31
US6054143A (en) 2000-04-25
ES2161666T3 (es) 2006-07-16
EP1063885A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
ATE320184T1 (de) Xylitolzusammensetzungen zur behandlung der oberen atmungsorgane
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
ES2124461T3 (es) Derivados de oxalilamino-benzofurano y de benzotienilo.
CY1115759T1 (el) Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
BR0113286A (pt) Pirazóis substituìdos
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR0011130A (pt) Inibidores de metaloproteases
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
ATE470446T1 (de) Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
EA200200137A1 (ru) Лечение невротических нарушений
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
SE9902267D0 (sv) New compounds
HUP0200152A2 (hu) KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
ATE309811T1 (de) Analgetikum aus schlangengift
DK1095059T3 (da) Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
DK1232173T3 (da) Nye fusidinsyrederivater
EA200400535A1 (ru) ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1063885

Country of ref document: EP